Dr. Russell Glen Buhr, MD

Dr. Buhr practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Buhr's NPI, 1295059749, was assigned on March 25, 2010. Dr. Buhr graduated from Keck School of Medicine of USC in 2010. Dr. Buhr holds California license A129932.

Dr. Buhr's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Buhr's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Buhr is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Buhr to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buhr practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Buhr's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Buhr is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Buhr's licenses on file in 3 states: California, Virginia and District of Columbia.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, tobacco use and upper respiratory infection (URI) among the conditions Dr. Buhr treats.

CMS data shows 256 Medicare services from Dr. Buhr across 5 procedure codes in 2024, for 100 Medicare patients. Medicare paid $18,536 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Buhr in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have copd, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buhr's median patient age at 65, with 53% women.

In 2024, Dr. Buhr wrote 736 Medicare Part D claims for 99 patients. CMS names the drug for 607 of them, across 19 drugs with 11 or more claims each, at $534,113 in total drug cost. In 2023, CMS named 475 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Buhr for performance year 2024, reported as part of a group. Dr. Buhr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buhr as offering telehealth.

Dmand AI links 14 papers to Dr. Buhr, published from 2018 to 2025. 2021 was the busiest year, with 5. Dr. Buhr's most frequent co-authors are Igor Barjaktarevic, MD, MS, Meilan King Han, MD and Robert J. Kaner, MD.

Dmand AI links Dr. Buhr to 4 clinical trials. 2 are still active or recruiting. Conditions studied include alpha 1-Antitrypsin Deficiency, Bronchitis, Chronic and Critical Illness.

CMS Open Payments shows 36 general payments to Dr. Buhr from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Mylan Inc. paid the most, $11,032.

Dmand AI lists 16 awards for Dr. Buhr, most recently Fellow in 2024.

Dr. Buhr graduated from Keck School of Medicine of USC in 2010. Dr. Buhr is a member of ACCP, ACP, AMA and ATS.

Dr. Buhr is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.